Results for 'oncologist'
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Monty Pal
Advancing Cancer Survivorship and Cardio-Oncology
City of Hope, Monty Pal, Saro Armenian, pediatric, cardio-oncology, CHIP clinic
Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.
Feb 24th • 39 mins listen
Monty Pal
The Future of Cancer Surgery: Innovations, AI, and Remote Robotics
City of Hope, Monty Pal, Yuman Fong, AI, robotics, surgical oncology, oncolytic virus, remote surgical procedure
Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of mentorship.
Mar 10th • 33 mins listen
Monty Pal
Pushing the Limits of Cancer Research and Surgery
City of Hope, Monty Pal, Mustafa Raoof, PIPAC, peritoneal, pancreatic cancer, surgical oncology
Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.
Apr 7th • 38 mins listen
Monty Pal
Expanding the Reach of TIL Therapy: What Will it Take?
City of Hope, Monty Pal, Kelly Mahuron, TIL, tumor-infiltrating lymphocyte, melanoma, oncolytic virus, pancreatic cancer, colorectal tumor, immunotherapyn
Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.
Aug 4th • 38 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Michael Pietrack
Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich
Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of…
May 27th • 19 mins listen
Michael Pietrack
Season 1, Episode 18: Challenges Facing the Pharma Universe with Jack West
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Jack West, the VP of Clinical Development at Summit Therapeutics. They discuss Jack's transition from being a practicing oncologist to working in the pharmaceutical industry, the importance of collaborations with pharm…
Sep 9th • 35 mins listen
Michael Pietrack
Season 2, Episode 18: Turning the Page with Chadi Nabhan
Join Michael Pietrack on the Pharmaverse Podcast as he sits down with Dr. Chadi Nabhan, MD – CMO and Head of Strategy at RyghtAI, hematologist, oncologist, author, and podcast host – to explore the future of clinical trials, AI innovation, and leadership in healthcare. In this episode, …
Sep 15th • 23 mins listen
ASCO Daily News Podcast
The Use of Biosimilars in Oncology
Host Dr. John Sweetenham, associate director of Clinical Affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, and Dr. Zeina Nahleh, breast cancer medical oncologist and regional chair of the Cleveland Clinic Florida Cancer Institute, discuss the new ASCO Expert Panel …
Mar 24th • 18 mins listen